Eurofarma Laboratórios S.A. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net income was BRL 241.35 million compared to BRL 238.36 million a year ago. Basic earnings per share from continuing operations was BRL 0.2811 compared to BRL 0.2776 a year ago. Diluted earnings per share from continuing operations was BRL 0.2811 compared to BRL 0.2776 a year ago.
For the nine months, net income was BRL 691.78 million compared to BRL 653.57 million a year ago. Basic earnings per share from continuing operations was BRL 0.8056 compared to BRL 0.7611 a year ago. Diluted earnings per share from continuing operations was BRL 0.8056 compared to BRL 0.7611 a year ago.